Precision Medicine Collaboration and Licensing Agreements Trends Report and Directory 2019-2025 | Benchmark Data for Dealmakers - Access Deal Records of Actual Deals As Disclosed by the Deal Parties - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Precision Medicine Collaboration and Licensing Deals 2019-2025" has been added to ResearchAndMarkets.com's offering.

This report contains a comprehensive listing of 1,221 precision medicine deals announced since 2019, including financial terms where available, and links to online deal records of actual precision medicine partnering deals as disclosed by the deal parties.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Precision Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the precision medicine deals entered into by the world's leading biopharma companies.

Fully revised and updated, the report provides details of precision medicine deals from 2019 to 2025. The report provides a detailed understanding and analysis of how and why companies enter precision medicine deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

The report includes collaboration, development, research, and licensing deals. The initial chapters of the report offer an overview of precision medicine dealmaking. Chapter 1 serves as an introduction, while Chapter 2 outlines the trends in precision medicine dealmaking since 2019. Chapter 3 highlights leading precision medicine deals by headline value, and Chapter 4 lists the top 25 most active companies with summaries and listings of deals. Chapters 5 and 6 provide detailed reviews of deals announced since Jan 2019, organized by contractor availability and technology focus respectively.

Precision Medicine Collaboration and Licensing Deals provides the reader with the following key benefits:

• Understand deal trends since 2019
• Browse precision medicine collaboration and licensing deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, deal type and therapy area
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Precision Medicine Collaboration and Licensing Deals includes:

• Trends in precision medicine dealmaking in the biopharma industry
• Directory of precision medicine deal records covering pharmaceutical and biotechnology
• The leading precision medicine deals by value
• Most active precision medicine licensing dealmakers

Analyzing contract agreements allows due diligence of:

• What are the precise rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in precision medicine dealmaking
2.1. Introduction
2.2. Precision medicine deals over the years
2.3. Most active precision medicine dealmakers
2.4. Precision medicine deals by deal type
2.5. Precision medicine deals by therapy area
2.6. Precision medicine deals by industry sector
2.7. Deal terms for precision medicine deals
2.7.1 Precision medicine deals headline values
2.7.2 Precision medicine deal upfront payments
2.7.3 Precision medicine deal milestone payments
2.7.4 Precision medicine royalty rates

Chapter 3 - Leading precision medicine deals
3.1. Introduction
3.2. Top precision medicine deals by value

Chapter 4 - Most active precision medicine dealmakers
4.1. Introduction
4.2. Most active precision medicine dealmakers
4.3. Most active precision medicine deals company profiles

Chapter 5 - Precision medicine contracts dealmaking directory
5.1. Introduction
5.2. Precision medicine contracts dealmaking directory

Chapter 6 - Precision medicine dealmaking by technology type

Deal directory

• Deal directory - Precision medicine deals by company A-Z
• Deal directory - Precision medicine deals by deal type
• Deal directory - Precision medicine deals by therapy area

Companies Featured

• 2bPrecise
• AbbVie
• Adaptive Biotechnologies
• Agilent Technologies
• Alnylam Pharmaceuticals
• Amgen
• Apollomics
• ArcherDX
• AstraZeneca
• Becton Dickinson
• Bayer
• Biogen
• BioNTech
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Caribou Biosciences
• Centogene
• Children's Hospital of Philadelphia
• Cleveland Clinic
• Columbia University
• CRISPR Therapeutics
• Dana-Farber Cancer Institute
• Decode Health
• Duke University
• Fred Hutchinson Cancer Research Center
• Genentech
• Gilead Sciences
• Google
• Harvard University
• Illumina
• Innovative Genomics Institute
• Johns Hopkins University
• Loxo Oncology
• Massachusetts General Hospital
• Mayo Clinic
• Merck & Co
• Microsoft
• MIT
• National Cancer Institute
• New York University
• Novartis
• Pfizer
• Roche
• St. Jude Children's Research Hospital
• Stanford University
• Thermo Fisher Scientific
• University of California San Francisco
• University of Cambridge
• Yale University
• ZS Pharma

For more information about this report visit https://www.researchandmarkets.com/r/he9wof

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.